Novo CEO pressed by Senate to chop selling prices of obesity, diabetic issues medicine CEO Lars Fruergaard Jørgensen explained to lawmakers the corporate would look at new talks with insurers concerning the list price ranges of Wegovy and copyright should they pledge to maintain the medicines on their formularies. Now https://caidenzpfwm.bligblogging.com/31227901/the-smart-trick-of-healthcare-news-that-nobody-is-discussing